5-amino-1mq daily dosage subcutaneous Injectable Healing Peptide BPC-157 Site Injection Instructional Video w/ John Tsikouris This is the first vote

Very Understanding

Patients with severe, longstanding deficiency typically require longer recovery periods, with haematological improvement occurring over weeks and neurological recovery potentially taking months

Longer prescriptions happen off-label and carry increased risk of tolerance and dependence

Topical serums on intact skin produce modest results (7% at 16 weeks)

It doesn't solely focus on weight reduction but aims to improve overall health and well-being through metabolic optimization

That triple mechanism is what produced the headline-grabbing results from the Phase 2 NEJM trial, where the 12 mg dose group achieved an average 24.2% body weight reduction over 48 weeks